Related Experiment Video
Updated: Jun 15, 2026

19:15
Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale
Published on: August 25, 2014
86.0K
Assessing for prenatal risk factors associated with infant neurologic morbidity using a multivariate analysis
Samhita Jain1, Scott Oltman2,3, Elizabeth Rogers4
1Division of Neonatology, Department of Pediatrics, University of California, San Francisco, CA, USA. Samhita.Jain@ucsf.edu.
Summary
Maternal immune activation (MIA) in pregnant individuals, influenced by factors like obesity and poverty, increases offspring susceptibility to neurologic conditions. Identifying MIA profiles aids in predicting these risks.
Area of Science:
- Obstetrics and Gynecology
- Neonatology
- Immunology
Background:
- Maternal immune activation (MIA) is a growing concern in pregnancy.
- Understanding MIA's impact on offspring neurologic development is crucial.
- Prenatal risk factors for MIA and subsequent infant morbidity require further characterization.
Purpose of the Study:
- To define the biochemical and demographic profiles of pregnant individuals experiencing MIA.
- To identify prenatal characteristics linked to neurologic morbidity in offspring.
- To develop predictive models for MIA and infant neurologic outcomes.
Main Methods:
- Retrospective cohort study of 602 mother-infant dyads.
- Analysis of mid-pregnancy biochemical markers and maternal demographic data.
- Multivariable logistic regression to build MIA vulnerability and neurologic morbidity profiles.
Main Results:
- A model with 2 demographic and 7 biochemical markers accurately identified mothers with MIA (AUC: 0.814).
- A combined profile of 3 demographic and 5 inflammatory markers predicted 80% of infants with neurologic morbidity (AUC: 0.802).
- Specific maternal risk factors like obesity, poverty, and prematurity were associated with increased susceptibility.
Conclusions:
- The inflammatory maternal environment, exacerbated by risk factors, heightens offspring vulnerability to neurologic morbidities.
- Predictive models incorporating demographic and biochemical markers can aid in identifying at-risk pregnancies.
- Early identification and intervention strategies are warranted for pregnancies with MIA risk factors.
More Related Videos
Related Concept Videos
Teratogenicity
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
Drug Toxicity: Risk factors
Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...

